Duo Xu

Also affiliated with Liaoning Cancer Hospital & Institute

Biochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Loss-of-function tolerance of enhancers in the human genome”.

Loss-of-function tolerance of enhancers in the human genome

PLoS Genetics(2020)10.1371/journal.pgen.1008663

N/A

0DataRank · unranked

16 citations

Ömer Gökçümen, Ekta Khurana, Duo Xu

Faculty Opinions recommendation of Titrating gene expression using libraries of systematically attenuated CRISPR guide RNAs.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature(2020)10.3410/f.737201390.793571722

N/A

0DataRank · unranked

0 citations

Duo Xu, Ekta Khurana

Recapitulation of patient-specific 3D chromatin conformation using machine learning

Cell Reports Methods(2023)10.1016/j.crmeth.2023.100578

N/A

0DataRank · unranked

8 citations

Andre Neil Forbes, Sandra Cohen, Ann Palladino, Tatiana Karadimitriou, Ekta Khurana +1 more

Discovery of therapeutic targets in cancer using chromatin accessibility and transcriptomic data

Cell Systems(2024)10.1016/j.cels.2024.08.004

N/A

0DataRank · unranked

9 citations

Duo Xu, Sandra Cohen, Priya Pancholi, Ekta Khurana, Andre Neil Forbes